CTEV
Claritev Corp
NYSE · Healthcare · Medical - Healthcare Information Services · US
$30.81
−2.90%Next report
Analyst consensus
- Next report date
- Nov 6, 2026
- EPS estimate
- -$3.63
- Revenue estimate
- $256.5M
Latest reported
- Last report date
- Aug 7, 2026
- EPS actual
- -$3.49
- EPS estimate
- -$4.12
- Revenue actual
- $257.5M
- Revenue estimate
- $244.8M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 2
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -176.9%
- Revenue beats (12Q)
- 5
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $40
- PT range
- $30 – $45
- Analysts
- 4
3 Buy1 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 7, 2026 | -$4.12 | -$3.49 | Beat 15.29% | $257.5M |
| May 7, 2026 | -$3.81 | -$4.41 | Miss -15.75% | $244.7M |
| Feb 23, 2026 | $0.85 | -$4.90 | Miss -676.75% | $246.6M |
| Nov 7, 2025 | -$3.12 | -$4.07 | Miss -30.45% | $246.0M |
| Aug 6, 2025 | -$2.69 | $0.32 | Beat 111.90% | $241.6M |
| May 8, 2025 | -$2.20 | -$3.43 | Miss -55.91% | $231.3M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 6, 2026